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Abstract
Background: PROCON was designed to assess the clinical outcome, development of adjacent
disc disease and costs of cervical anterior discectomy without fusion, with fusion using a stand alone
cage and implantation of a Bryan's disc prosthesis. Description of rationale and design of PROCON
trial and discussion of its strengths and limitations.
Methods/Design: Since proof justifying the use of implants or arthroplasty after cervical anterior
discectomy is lacking, PROCON was designed. PROCON is a multicenter, randomized controlled
trial comparing cervical anterior discectomy without fusion, with fusion with a stand alone cage or
with implantation of a disc. The study population will be enrolled from patients with a single level
cervical disc disease without myelopathic signs. Each treatment arm will need 90 patients. The
patients will be followed for a minimum of five years, with visits scheduled at 6 weeks, 3 months,
12 months, and then yearly. At one year postoperatively, clinical outcome and self reported
outcomes will be evaluated. At five years, the development of adjacent disc disease will be
investigated.
Discussion: The results of this study will contribute to the discussion whether additional fusion
or arthroplasty is needed and cost effective.
Trial registration: Current Controlled Trials ISRCTN41681847
Background
Since the first description of the cervical anterior discec-
tomy with fusion by Cloward and Smith and Robinson in
1958 respectively in 1955[1,2], and the cervical anterior
discectomy without fusion in 1960 by Hirsch[3] a debate
is started which of both methods is the best. While this
discussion is still not closed[4], the advent of the cervical
disc prosthesis has contributed to extra confusion. Instead
of two possibilities, nowadays three possible treatments
concur with each other: cervical anterior discectomy with-
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out implantation of any structure (CAD), cervical anterior
discectomy with fusion (CADF), and finally, cervical dis-
cectomy with implantation of a disc prosthesis (CADP).
Numerous clinical studies have been published. Several
prospective, randomized trials have been reported [5-10].
However, methodological flaws as non homogenous
patient population, undefined randomization process,
small sample sizes, unclear outcome measurements and
substantial loss of patients for follow – up, preclude defi-
nite conclusions regarding the efficacy of CAD versus
CADF.
Recently, the results of a prospectively followed cohort
have been published. They clearly showed that a cervical
disc prosthesis is a safe devices[11]. However, one should
bear in mind that the follow – up is short.
Several randomized controlled studies comparing arthro-
plasty and fusion with a plate have been reported with
short follow – up or are still ongoing. CADF with a plate
is defined as the gold standard[12,13]. This is very odd,
since evidence has never been provided that cervical dis-
cectomy with fusion is better than without[4]. The use of
a plate is even debatable[14].
Since the costs of implants are enormous, sound clinical
evidence is needed to justify their use. Therefore, a pro-
spective, randomized trial was developed comparing
CAD, CADF using a cage, and CADP. Due to the experi-
ence of the principal investigators, the Bryan's disc pros-
thesis was chosen. The design of this trial is described and
some of its strengths and limitations discussed. It is called
the PROCON trial referring to the pro's and con's that are
obvious present for each form of treatment.
Methods/Design
Study aims
PROCON has three aims:
1. to conduct a multicentre, randomized controlled trial
comparing the clinical outcome of the different surgical
options: CAD, CADF using a cage and, finally, CADP with
implantation of a Bryan's disc prosthesis with a repeated
longitudinal measurement up to 12 months.
2. to define differences in disc degeneration of the adja-
cent discs between the three surgical options. For this pur-
pose, the patients will be followed for 60 months. All
intercurrent treatments for cervical disc disease are
recorded. A magnetic resonance imaging (MRI) scan will
be performed 60 months after surgery.
3. to estimate the cost-effectiveness of the three surgical
options.
Study sites
The clinical centers that are planned to recruit patients
into PROCON are located in the Netherlands: University
Medical Center St. Radboud, Nijmegen; Canisius Wil-
helmina Hospital, Nijmegen; St. Elisabeth Hospital,
Tilburg, and finally, De Haaglande Hospital in The Hague.
Study population
To obtain a homogenous patient population the follow-
ing in – and exclusion criteria will be employed.
Inclusion criteria
All adult patients aged between 18 and 55 years with
monoradicular signs and symptoms in the arm due to a
herniated cervical intervertebral disc and/or an osteophyt
at MRI are eligible for PROCON. The radiological findings
should be in accordance with the clinical presentation.
Furthermore, at the preoperative dynamic lateral X – ray
the involved level should not have been fused. In – and
exclusion criteria are represented in Table 1.
Recruitment and Enrollment
Participating physicians at each site identify possible can-
didates. After their eligibility is controlled by one of the
two principal investigators, the patients are informed
about the PROCON trial. Seven days later, the patients are
contacted again and informed consent is obtained from
those willing to participate. Data regarding demographic
Table 1: Inclusion – and exclusion criteria
Inclusion Exclusion
Age: 18 – 55 years Symptoms and/or signs of myelopathy
Cervical monoradicular symptoms Previous cervical surgery
MRI: herniated cervical intervertebral disc and/or osteophyte in accordance with 
clinical symptoms and signs
Psychiatric or mental disease
Involved level not fused Involvement of liability procedure
Alcoholism (drinking more than 5 units)
Insufficient of the Dutch language
Participation in another study
Two or more levels involvedBMC Musculoskeletal Disorders 2006, 7:85 http://www.biomedcentral.com/1471-2474/7/85
Page 3 of 6
(page number not for citation purposes)
characteristics, medical history and comorbidity, signs
and symptoms, and baseline measurements for all out-
comes are obtained through patient interview, patient
self-administered survey, and physician survey.
Randomization
For randomisation, the closed envelope method is used.
As soon as informed consent is obtained, one of the treat-
ment options is assigned to the patient. Prior to surgery,
the patient is informed about the chosen option. Patients
who do not choose for participation, are offered one of
the surgical options that are currently under investigation.
However, they are not followed in an observational
cohort study.
Study interventions
Three techniques are subject of study. A standard anterior
cervical discectomy with the aid of a microscope is used in
all cases. Whether the approach is from the left or right
side is up to the preference of the surgeon. In case of CAD,
the wound is closed after adequate decompression of the
neural elements. However, if a fusion is chosen a cage
(cervical I/F, Depuy Acromed, Johnson and Johnson,
Amersfoort, The Netherlands) filled with bone substitute
is placed within the intervertebral space. Although a nee-
dle technique for obtaining bone from the iliac crest with
minimal pain has been described[15], the cage is filled
with a commercially available bone substitute (beta – tri-
calcium phosphate) to prevent the pain from the iliac
crest. The preparation for implantation of the Bryan's disc
prosthesis (Sofamor Danek, Medtronic, Kerkrade, The
Netherlands) is done before or after the standard cervical
discectomy. Of course, the implantation of the prosthesis
itself follows the discectomy. To prevent calcification
along the prosthesis, the patients are prescribed meloxi-
cam 15 mg daily for 14 days. The patients within the other
two groups are prohibited to take non – steroidal – anti –
inflammatory drugs (NSAIDs) for 14 days postopera-
tively.
All patients are encouraged to mobilize as soon as possi-
ble. A collar is never prescribed.
Follow – up
Follow-up data are gathered at 6 weeks, 3 months and 12
months. Until 12 months the clinical assessment is done
by an independent neurologist. Thereafter, the treating
surgeon will coordinate follow – up and clinically assess
the patient. At 12 months a computed tomography (CT)
is made to evaluate fusion. In the prosthesis group, para-
vertebral calcifications within the long colli muscles can
be ruled out. From one year until five years postopera-
tively, the patient is seen annually. At each visit plain X
rays with flexion and extension of the cervical spine are
made. Questionnaires are also filled out. Sixty months
postoperatively, a MRI study is performed. Sagittal T1, T2
and proton density images will be obtained to obtain
information about the adjacent disc.
Outcomes
The primary outcome measure is the clinical and health-
related quality of life after one year postoperatively as
measured by both generic and disease specific instru-
ments. Secondary endpoints include work status, fusion
rate after 1 year, the development of a cervical kyphotic
deformity at 1 and 5 years, and the incidence of adjacent
disc disease at 5 years postoperatively.
Primary outcomes
SF – 36 Health Status Questionnaire is a widely-used
generic health status. This instrument consists of eight
subscales and two summary scales. On each scale higher
scores indicate better outcomes. Scores can be compared
with published age – and sex – matched general popula-
tion or disease-specific norms[16].
The McGill Pain score consists of four parts: 1) a list of
words to describe the quality and intensity of the pain, 2)
questions about the effects of the pain on daily life, 3) vis-
ual analogue scales, and 4) questions about the distribu-
tion and course of the pain. The McGill pain score is
highly effective to measure the effects of a treatment on
pain[17]. The Dutch version of this score is called the
MPQ – DLV: McGill pain questionnaire – Dutch language
version[17,18].
Neck Disability Index (NDI)
The NDI is a validated 10 – item questionnaire, that meas-
ures activity limitations due to neck pain. It is a self –
reported instrument for the assessment of ADL, and it is a
revised form of the Oswestry Low Back Pain Index[19,20].
Work Limitations Questionnaire (WLQ)
The WLQ is a 25 – item questionnaire developed to meas-
ure health – related decrements in ability to perform job
roles among employed individuals. Patients themselves
fill in the questionnaire. The WLQ scale scores have been
proven to be sensitive to changes in health status over
time [21].
Secondary outcomes
The impact of surgery on working status is evaluated by
calculating the duration before the patients fully resume
normal activities. We will also document whether the
patients are capable returning to their original jobs or if
they have to change their work. The work limitations
questionnaire is used to obtain a score that reflects the
amount of discomfort the patient have performing their
job. The pre-intervention scores are the baseline for followBMC Musculoskeletal Disorders 2006, 7:85 http://www.biomedcentral.com/1471-2474/7/85
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– up. The mean differences are compared between the
treatment arms.
Radiologic examinations are performed preoperatively
and at each follow – up visit. At one year, a radiologist
evaluates whether there is fusion on CT and plain X-Ray.
The angle between the adjacent vertebrae is measured
when the patient is holding the neck in neutral position
while sitting. The angle between the endplate of the sec-
ond cervical vertebral body and the upper endplate of the
seventh cervical vertebra is also determined. Furthermore,
this is also done when the patient maximally flexes or
extends the neck. At five years postoperatively, the same
evaluation is done. The development of anterior osteo-
phytes of decrease of disc height of the adjacent levels is
noted. Changes in time are determined within each treat-
ment arm. The mean values are also compared between
each treatment arm at 1 year and 5 year follow – up.
Finally, at five years follow – up a MRI is made to evaluate
whether a change of the quality of the intervertebral discs
of the adjacent level can be shown.
Cost – effectiveness
The aim of cost – effectiveness analysis is to reveal how
differences in clinical outcome between the three surgical
techniques relate to differences in their resource require-
ments. To this end, volumes of major cost drivers such as
hospitalisation, medication use, out – patients consulta-
tions etcetera will be registered for each individual. For
cost prices, national guidelines will be used. If differences
are observed between the groups in resumption of work,
costs of lost productivity will be estimated using the fric-
tion – cost method. Incremental cost – effectiveness ratios
will be calculated: uncertainty of these estimates will be
determined using bootstrap techniques[22].
Monitored events
Monitored events are the death of a patient, withdrawal
from the study, lost to follow – up, and cross – over from
their randomly assigned treatment group. These events are
registered within the case record form. The circumstances
of the events are investigated and also noted. In case of
death of the patient, a search for a relationship with the
instituted treatment is started. Throughout the study, all
medical complications and intervening treatments con-
cerning the cervical spine are registered within the CRF at
the usual follow – up visits or when the appropriate infor-
mation reaches the treating surgeon.
Protocol violations
Any of the following will be considered as a deviation
from the protocol: randomization of an ineligible patient,
enrollment of a patient that is already participating in an
another study, enrollment of an PROCON participant in
another study, a patient receiving the wrong treatment,
loss of radiology or any other data, and informed consent
violations. Violations are reviewed biweekly and reported
to the independent study supervisor.
Statistical Analysis
Our primary analysis is based on the intention to treat
principle.
The primary study endpoints will be measured as changes
from pre-intervention baseline scores. The mean scores of
the three treatment arms will be compared at each follow-
up time.
Sample size calculations were based on the outcome
reported in literature. An excellent outcome (no com-
plaints at all) is generally achieved in 60% of the patients,
that underwent CAD or CADF. An increase of 20% was
found acceptable to justify the use of a prosthesis.
With a power of 80 % and a two – sided level of signifi-
cance of 0.05, a chi-square analysis would need 81
patients per group. Assuming a loss to follow – up of 10
%, a total of 270 patients are needed.
No subgroup analyses are planned, nor any interim –
analyses.
Organization of the study
The coordinating center of the study is located at the Can-
isius Wilhelmina Hospital, Nijmegen, The Netherlands,
and at the University Medical Center Nijmegen St. Rad-
boud. Technically, four groups exist within the organiza-
tion. The first one is the trial direction, consisting of the
leading investigators who also enroll patients in the study.
They coordinate activities and liaise with other participat-
ing studies. The second one is the group of independent
neurologists and radiologists. They are not involved in the
coordination of the study. The third group is the medical
technology assessment. They are involved in the develop-
ment of the study protocol. They also control the input of
data and perform statistical analysis of the data. The
fourth and last group, is the independent supervising phy-
sician. He is a neurologist without experience in spine
pathology. He does not examine patients for the study.
Violations against the protocol are reported to him. He is
also the contact person for those patients that have com-
plaints not related to their disease or treatment (e.g. about
the doctor). Patients can also contact him if they have
questions during the study, about the study or are in
doubt whether or not to participate.
Discussion
Despite the lack of evidence in favour of one of the possi-
ble procedures, during the last decade the number of
fusions has increased dramatically in the United States,BMC Musculoskeletal Disorders 2006, 7:85 http://www.biomedcentral.com/1471-2474/7/85
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whereas the total number of cervical spine procedures
remained relatively constant[23]. The costs of fusion are
considerable. In the Netherlands, a plate costs about 500
euro's and a cage about 700 euro's. The price of a disc
prosthesis is even higher, about 2500 euro's. In the United
States, disc prostheses are booming business. It is esti-
mated that the market could approach $1.7 billion a year
by 2010[24].
Apart from the clinical effectiveness, it is obvious that
studies are needed to justify the enormous costs of fusion
or arthroplasty. Several studies are conducted comparing
arthroplasty with fusion. The design of this study is
unique, since it does add an extra treatment arm, cervical
anterior discectomy without fusion.
Several problems may arise. Randomization may not be
easily accepted by patients. However, from a previous ran-
domized controlled trial comparing surgical tech-
niques[25], we learned that correct description of
possibilities and estimated outcomes patients are not
reluctant to participate. Especially the fact that no proof
exists for one or another treatment will increase accept-
ance.
Surgery may have a placebo effect[26]. Clinical objective
outcome is measured, but also self reported outcomes.
PROCON is not able to determine a possible placebo
effect. Although it must be considered a limitation of the
study, its clinical value should also be questioned.
External validity and generalizability is often discussed.
Patient selection is restricted to one level cervical disease
without myelopathy. Therefore, the results cannot be
extrapolated to two or more level disease, nor to patients
with myelopathic symptoms and signs. On the other
hand, the restriction to one level disease does prevent the
need for stratification and loss of power during statistical
analysis.
Although surgical skill may differ, a microscopic cervical
anterior discectomy is a rather standard and straightfor-
ward technique. The use of the same implants does not
allow variation due to construct design. Therefore, we do
not feel that variation in skill will seriously affect the out-
come of the study.
The second part of PROCON is the radiological evalua-
tion of the development of adjacent disc disease. The pre-
intervention plain X Rays are used as baseline study. The
development of osteophytes or the increase of existing
osteophytes may be a measure for the progression of adja-
cent disc disease. At five years postoperatively, an MRI is
made to judge the quality of the adjacent discs. The ques-
tion raises whether this time is long enough. At five years,
adjacent disc disease may not have been fully developed,
and perhaps its prevalence is not high enough to be statis-
tically significant. However, extension of follow up time
would severely compromise the inclusion of patients, and
would also induce a high number of loss to follow up.
Finally, PROCON does measure costs. It is questionable if
these findings can be extrapolated to other countries. First,
the fee for hospitals and doctors are different. Secondly
and probably most importantly, the compensation for
sick leave is very differently arranged compared to other
countries. Patients feel less urge to resume their daily
working activities[27]. Therefore, the external validity of
results of the cost effectiveness or cost minimization study
will be extremely low, although tendencies might be for-
mulated.
Conclusion
Cervical anterior discectomy is frequently performed. The
need for a randomized controlled trial comparing the cer-
vical discectomy without fusion, with fusion and the
newer technique arthroplasty is obvious. The costs of
implants are enormous, whereas their effectiveness has
never been proved. The design of such a study, and some
of its limitations are discussed.
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